Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-05-05

Clinical Trial Update: Effectiveness of Naltrexone and/or Ondansetron to Reduce Craving for Alcohol and Drinking [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating whether naltrexone and/or ondansetron can reduce cravings for alcohol and drinking in individuals with Alcohol Dependence. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone (Naltrexone)
  • Ondansetron (ondansetron)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Alcohol Dependence | Phase 2 | Status: COMPLETED